Therefore, mice with tumors derived from sarcoma S23, with a poor prognosis and high pH2AX and MAP17 levels, showed better survival rates than mice with tumors derived from sarcoma S27 after treatment with olaparib plus doxorubicin. This evidence concerns the gene PDZK1IP1 and sarcoma.